Deakin University
Browse

Phase II evaluation of PIV3 cp45 live, attenuated parainfluenza type 3 vaccine in healthy children 6-18 months of age

Version 2 2024-06-19, 10:03
Version 1 2022-03-31, 12:34
conference contribution
posted on 2024-06-19, 10:03 authored by EL Anderson, RB Belshe, FK Newman, R Karron, P Wright, D Roberton, K Reisinger, F Henderson, J King, R Loh, P Sly, P McIntyre, J Ziegler, H Keyserling, R Schwartz, G Weinberg, B Murphy, J Tatem, F Gohs, T Tsai, J Hackell, W Gruber
Phase II evaluation of PIV3 cp45 live, attenuated parainfluenza type 3 vaccine in healthy children 6-18 months of age

History

Volume

51

Pagination

281A-281A

ISSN

0031-3998

Language

English

Publication classification

E3.1 Extract of paper

Title of proceedings

PEDIATRIC RESEARCH

Issue

4

Publisher

INT PEDIATRIC RESEARCH FOUNDATION, INC

Usage metrics

    Research Publications

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC